Sanos Group
Sanos Group is a Denmark-based multi-niche CRO serving pharmaceutical, biotech, and academic clients across 35+ countries, specializing in musculoskeletal, neurological, and dermatological clinical trials with integrated Phase I, GMP depot, and eCOA technology capabilities.
- Company typePrivate
- Founded2006
- HeadquartersSøborg, Denmark
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Sanos Group does
Sanos Group is a Denmark-based, multi-niche Contract Research Organization (CRO) founded in 2006 and headquartered in Søborg. The company operates through specialized subsidiaries covering three therapeutic niches: NBCD (musculoskeletal), Neuroscios (neurological diseases including Alzheimer's, Parkinson's, and ALS), and Blueskin (dermatology including psoriasis and atopic dermatitis). Its service portfolio spans the full clinical trial lifecycle, including Phase I clinical pharmacology through Sanos Clinic, GMP-certified clinical trial supply and depot services through Sanos Supply, and proprietary electronic Clinical Outcome Assessment (eCOA) technology through Studies&Me, which was spun out from Nordic Bioscience's IT operations in 2021.
The company employs approximately 250 staff across operations in Denmark, Germany, and the USA, with active clinical trial reach extending to over 35 countries. Sanos serves pharmaceutical companies, biotech firms, and academic institutions under a fixed-budget pricing model, with revenue derived from professional services, managed services, and recurring eCOA subscription contracts. The leadership team, led by Group CEO Jeppe Ragnar Andersen, brings 20-30 years of therapeutic expertise, supported by 200+ peer-reviewed publications and a track record of 18,000+ patients in studies led by the CEO.
Since 2020, Sanos has executed a roll-up strategy funded by a majority investment from InvestCorp, acquiring three niche CROs and vertically integrating Phase I capabilities, supply chain, and eCOA technology. The company's strategic focus is on building a differentiated, multi-niche CRO platform that combines deep therapeutic expertise, integrated technology, and GMP-certified infrastructure to compete with full-service global CROs in specialized indications.
Sanos Group firmographics
Firmographics- Name
- Sanos Group
- Legal name
- Sanos Group ApS
- Website
- https://sanos.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Sanos Group is a Denmark-based multi-niche CRO serving pharmaceutical, biotech, and academic clients across 35+ countries, specializing in musculoskeletal, neurological, and dermatological clinical trials with integrated Phase I, GMP depot, and eCOA technology capabilities.
- Ownership category
- akta.pro rank
Sanos Group industry classification
Industry- Product category
- Clinical Research Services (Contract Research Organization)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
Keywords
Where Sanos Group is headquartered
LocationHeadquarters
- HQ city
- Søborg
- HQ country
- Denmark
- HQ region
- Europe
Offices4 records
Markets served
Sanos Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Full-Service CRO Services: Comprehensive clinical trial management services from study feasibility and protocol design to regulatory affairs, risk-based monitoring, and statistical analysis. Services span early-phase development through large-scale Phase I-III trials with fixed-budget pricing model.
- Clinical Supply Logistics: GMP-certified storage, packaging, labeling, and global distribution services for investigational medicinal products through Sanos Supply division.
- eCOA Technology Solutions: Electronic Clinical Outcome Assessment solutions including AnneaPRO and eDairy platforms for data collection in clinical trials.
- Research Clinic Services: Patient recruitment, site management, and clinical trial execution services through Sanos Clinic network with dedicated Phase I unit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Fixed Budget Model |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Sanos Group product offering
Product offeringCore offering
Sanos Group is a multi-niche Contract Research Organization that plans and runs clinical trials for pharmaceutical and biotechnology sponsors across musculoskeletal, neurological, and dermatological therapeutic areas. Its offering spans full-service clinical trial management, eCOA technology (AnneaPRO, eDairy), digital patient recruitment (Studies&Me), a GMP-certified clinical supply depot (Sanos Supply), and dedicated research clinics including a Phase I unit (Sanos Clinic), delivered under fixed-budget, fixed-timeline contracts.
Differentiator
Problem solved
Functional benefit
Products and services
- Full-Service CRO Services
- eCOA Solutions (AnneaPRO and eDairy)
- Sanos Supply (GMP Clinical Trial Supply)
- Patient Recruitment (Studies&Me)
- Sanos Clinic (Research Clinics with Phase I Unit)
- Biostatistics and Data Science Services
Quantifiable outcome
- One of the highest patient retention rates in clinical trials
- +2 more outcomes
Companies that use Sanos Group
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Sanos Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Sanos Group partnerships and signals
Strategic signalScale indicators7 records
Recent moves10 records
Expansion highlights5 records
Sanos Group competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Large clinical-to-commercial CRO with significant biotech sponsor focus, currently privately held following Elliott/Patient Square take-private. Comparable scale tier and full-service CRO scope competing for Sanos' enterprise sponsor relationships.
- Charles River Laboratories: Large publicly traded CRO/CDMO offering preclinical through clinical research services globally. Comparable end-to-end clinical and supply chain capabilities (Sanos Supply mirrors parts of Charles River's manufacturing/distribution), but with significantly broader scope and scale.
- ICON plc: Top-tier global CRO offering full-service clinical development including biotech-focused PRA Health Sciences division. Comparable end-to-end service model competing for the same enterprise sponsor contracts as Sanos.
- IQVIA: Largest global full-service CRO with R&D Solutions and technology platforms. Direct competitor for large enterprise Phase III trials Sanos is targeting, and a comparable provider of clinical supply, eCOA, and real-world data services.
Direct peers
- Medpace Holdings: Mid-sized, therapeutically focused full-service CRO with strong margins and a science-led operating model. Highly comparable to Sanos in therapeutic specialization strategy, mid-tier scale, and B2B pharma/biotech sponsor focus, though materially larger (~5,500+ employees).
- Celerion: Specialty early-phase clinical research organization with dedicated Phase I clinic network and bioanalytical lab services. Comparable to Sanos Clinic's Phase I unit and Sanos' early-phase clinical development focus.
- Premier Research: Specialty CRO focused on biotech and rare disease trials across multiple therapeutic areas including neuroscience and dermatology. Comparable multi-niche specialty model serving small-to-mid biotech sponsors with similar scope to Sanos.
- Worldwide Clinical Trials: Privately held, mid-sized multi-niche CRO with therapeutic focus in neuroscience, cardiometabolic, and rare diseases. Closely comparable to Sanos' multi-niche specialty positioning and similar employee scale (~1,500-2,000).
- Clario: Leading provider of eCOA, cardiac safety, and clinical endpoint technology solutions formed from ERT and Bioclinica merger. Most direct competitor to AnneaPRO and eDairy eCOA platforms within Sanos' technology portfolio.
Others
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Sanos Group social profiles
Digital presenceSanos Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sanos Group leadership team
Management profileNumber of profiles
Profiles17 records
Sanos Group subsidiaries and ownership
Company hierarchySubsidiaries6 records
Sanos Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sanos Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sanos Group
What does Sanos Group do?
Sanos Group is a multi-niche Contract Research Organization that plans and runs clinical trials for pharmaceutical and biotechnology sponsors across musculoskeletal, neurological, and dermatological therapeutic areas. Its offering spans full-service clinical trial management, eCOA technology (AnneaPRO, eDairy), digital patient recruitment (Studies&Me), a GMP-certified clinical supply depot (Sanos Supply), and dedicated research clinics including a Phase I unit (Sanos Clinic), delivered under fixed-budget, fixed-timeline contracts.
Is Sanos Group a public or private company?
Sanos Group is a private company. It is classified as private equity controlled and is currently operating.
When was Sanos Group founded?
Sanos Group was founded in 2006. It employs 101 to 250 people.
Where is Sanos Group based?
Sanos Group is headquartered in Søborg, Denmark, in the Europe region.
How does Sanos Group make money?
Four revenue lines are on record. Full-Service CRO Services are the primary driver. The others are clinical Supply Logistics, eCOA Technology Solutions and research Clinic Services.
Who are Sanos Group's main competitors?
Broad incumbents on record are Syneos Health, Charles River Laboratories, ICON plc and IQVIA. Direct peers are Medpace Holdings, Celerion, Premier Research, Worldwide Clinical Trials and Clario. Medidata Solutions (Dassault Systèmes) is listed as an others.
Does Sanos Group have an API?
No public API is recorded for Sanos Group.
What industry is Sanos Group in?
Sanos Group's product category is Clinical Research Services (Contract Research Organization). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease).